Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Metformin Reduces Lipid Accumulation in Hepg2 Cells Via Downregulation of Mir-33B Publisher Pubmed



Zare M1 ; Panahi G2 ; Koushki M2 ; Mostafavipour Z1, 3 ; Meshkani R2
Authors

Source: Archives of Physiology and Biochemistry Published:2022


Abstract

Introduction: Here, we aimed to investigate whether the beneficial effects of metformin on lipid accumulation is mediated through regulation of miR-33b. Methods: The expression of the genes and miRNAs and protein levels were evaluated using real-time PCR and western blot, respectively. To investigate the potential role of miR-33b in lipid accumulation, the mimic of the miR-33b was transfected into HepG2 cells. Results: We found that metformin reduces high glucose-induced lipid accumulation in HepG2 cells through inhibiting of SREBP1c and FAS and increasing the expression of CPT1 and CROT. Overexpression of miR-33b significantly prevented the decreasing effect of metformin on lipid content and intra and extra triglyceride levels. Importantly, miR-33b mimic inhibited the increasing effects of metformin on the expression of CPT1 and CROT. Conclusion: These findings suggest that metformin attenuates high glucose-induced lipid accumulation in HepG2 cell by downregulating the expression of miR-33b. © 2019 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Exploring Serum Mir-33B As a Novel Diagnostic Marker for Hypercholesterolemia and Obesity: Insights From a Pilot Case-Control Study, BMC Endocrine Disorders (2025)
2. Targeting Mirna by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver, Evidence-based Complementary and Alternative Medicine (2021)
3. Aerobic Endurance Training Improves Nonalcoholic Fatty Liver Disease (Nafld) Features Via Mir-33 Dependent Autophagy Induction in High Fat Diet Fed Mice, Obesity Research and Clinical Practice (2018)
Experts (# of related papers)
View all Related Experts
Reza Meshkani (9)
Farideh Razi (3)
Other Related Docs
4. Decreased Serum Level of Mir-155 Is Associated With Obesity and Its Related Metabolic Traits, Clinical Laboratory (2018)
5. Combinational Administration of Mesenchymal Stem Cell-Derived Exosomes and Metformin Reduces Inflammatory Responses in an in Vitro Model of Insulin Resistance in Hepg2 Cells, Heliyon (2023)
6. Managing Cardiovascular Events, Hyperglycemia, and Obesity in Type 2 Diabetes Through Microrna Regulation Linked to Glucagon-Like Peptide-1 Receptor Agonists, Diabetology and Metabolic Syndrome (2025)
7. Chlorogenic Acid Improves Anti-Lipogenic Activity of Metformin by Positive Regulating of Ampk Signaling in Hepg2 Cells, Cell Biochemistry and Biophysics (2022)
8. Unveiling the Role of Mir-186 in Sirt1 Regulation in Adipocytes: Implications for Adipogenesis and Inflammation in Obesity, Journal of Diabetes and Metabolic Disorders (2025)
9. Dietary Regulation of Mir-33B and Mir-29A in Relationship to Metabolic Biomarkers of Glucose and Lipids in Obese Diabetic Women: A Randomized Clinical Controlled Study, Iranian Red Crescent Medical Journal (2017)
10. Microrna-141 Is Associated With Hepatic Steatosis by Downregulating the Sirtuin1/Amp-Activated Protein Kinase Pathway in Hepatocytes, Journal of Cellular Physiology (2020)
11. The Regulation of Efferocytosis Signaling Pathways and Adipose Tissue Homeostasis in Physiological Conditions and Obesity: Current Understanding and Treatment Options, Obesity Reviews (2022)
12. Inhibiting Mir-27A and Mir-142-5P Attenuate Nonalcoholic Fatty Liver Disease by Regulating Nrf2 Signaling Pathway, IUBMB Life (2020)
13. Resveratrol Reduces Lipid Accumulation Through Upregulating the Expression of Micrornas Regulating Fatty Acid Bet Oxidation in Liver Cells: Evidence From In-Vivo and In-Vitro Studies, Iranian Journal of Pharmaceutical Research (2020)
14. Micrornas As the Actors in the Atherosclerosis Scenario, Journal of Physiology and Biochemistry (2020)
15. Metformin and Its Potential Influence on Cell Fate Decision Between Apoptosis and Senescence in Cancer, With a Special Emphasis on Glioblastoma, Frontiers in Oncology (2024)
16. Downregulated Microrna-155 Expression in Peripheral Blood Mononuclear Cells of Type 2 Diabetic Patients Is Not Correlated With Increased Inflammatory Cytokine Production, Cytokine (2015)
17. Decreased Serum Microrna-21 Level Is Associated With Obesity in Healthy and Type 2 Diabetic Subjects, Archives of Physiology and Biochemistry (2018)
18. Nlrp3 Inflammasomes Pathway: A Key Target for Metformin, Inflammopharmacology (2025)
19. Hyperglycemic Memory: Observational Evidence to Experimental Inference, Current diabetes reviews (2025)
20. Decreased Expression of Microrna-21 Is Associated With Increased Cytokine Production in Peripheral Blood Mononuclear Cells (Pbmcs) of Obese Type 2 Diabetic and Non-Diabetic Subjects, Molecular and Cellular Biochemistry (2016)